Evidence map›Paper›PMID 12086584›Full record

ArticleThe Biochemical journal2002

Induction of apoptosis in human leukaemic cells by IPENSpm, a novel polyamine analogue and anti-metabolite.

Alison V Fraser, Patrick M Woster, Heather M Wallace

Open access · bronzeAbstract read
In one paragraph

Article in The Biochemical journal, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. A perspective of polyamine metabolism.The Biochemical journal · 2003
    Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Alison V FraserDepartments of Medicine & Therapeutics and Biomedical Sciences, Polwarth Building, University of Aberdeen, Foresterhill, Aberdeen, AB25 2ZD, Scotland, U.K.
Patrick M Woster
Heather M Wallace
University of Aberdeen · GB

Funding

ANTINEOPLASTIC POLYAMINE ANALOGUESR01CA085509 · NCI · WAYNE STATE UNIVERSITY · PI WOSTER, PATRICK M · 2000 to 2004
$1.2M
NCI NIH HHS R01 CA085509
6 · The paper itself

Abstract

Human promyelogenous leukaemic cells (HL-60) were treated with novel spermine analogue, ( S )- N (1)-(2-methyl-1-butyl)- N (11)-ethyl-4,8-diazaundecane (IPENSpm), and the effects on growth and intracellular polyamine metabolism were measured. IPENSpm was cytotoxic to these cells at concentrations greater than 2.5 microM. It induced apoptosis in a caspase-dependent manner and its toxicity profile was comparable with etoposide, a well-known anti-tumour agent and inducer of apoptosis. IPENSpm decreased intracellular polyamine content as a result of changes in ornithine decarboxylase activity and increases in spermidine/spermine N(1)-acetyltransferase and polyamine export. Analysis showed spermine and spermidine as the major intracellular polyamines, while putrescine and acetyl-polyamines were the main export compounds. IPENSpm used the polyamine transporter system for uptake and its accumulation in cells was prevented by polyamine transport inhibitors. IPENSpm can be classified as a polyamine anti-metabolite and it may be a promising new lead compound in terms of treatment of some human cancers.

Indexed as

ApoptosisAcetyltransferasesAntimetabolitesCaspasesDiamine N-AcetyltransferaseDose-Response Relationship, DrugEtoposideHL-60 CellsHumansLeukemiaNucleic Acid Synthesis InhibitorsPolyaminesTime FactorsTumor Cells, CulturedAcetyltransferasesAntimetabolitesCaspasesDiamine N-AcetyltransferaseEtoposideN(1)-ethyl-N-(11)-(2-methyl-1-butyl)-4,8-diazaundecaneNucleic Acid Synthesis InhibitorsPolyamines

Identifiers

PMID12086584
PMCPMC1222862
OpenAlexW2090976684

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.